Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 19 and 74 at the time of signing up for the study
- People who are willing to voluntarily sign a consent form agreeing to take part in the study
- People who have been diagnosed with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer linked to a BRCA gene mutation (confirmed or suspected, inherited or developed over time), and who have been taking a stable dose of olaparib for more than 3 months before the screening stage
Who may not be able to join:
- People who have had a severe allergic reaction to any ingredient in the study drug, or who have a history of a clinically significant allergic reaction to similar medications
- People who have a digestive or gastrointestinal condition (such as acid reflux disease, stomach spasms, gastritis, stomach ulcers, or Crohn's disease) or who have had stomach or bowel surgery (other than appendix removal or hernia repair) that could affect how the body absorbs the study drug
- People who are pregnant, possibly pregnant, or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82 2-708-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pharmacokinetic variable - Cmax; Pharmacokinetic variable - AUCtau
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.